Hospital Israelita Albert Einstein, Sao Paulo, SP, BR.
Clinics (Sao Paulo). 2021 May 21;76:e2812. doi: 10.6061/clinics/2021/e2812. eCollection 2021.
We sought to analyze the hemodynamic effects of the multilayer flow-modulated stent (MFMS) in Thoracoabdominal aortic aneurysms (TAAAs).
The hemodynamic effects of MFMS were analyzed in aortic thoracoabdominal aneurysms in experimental swine models. We randomly assigned 18 pigs to the stent or control groups and underwent the creation of an artificial bovine pericardium transrenal aneurysm. In the stent group, an MFMS (Cardiatis, Isnes, Belgium) was immediately implanted. After 4 weeks, we evaluated aneurysm sac thrombosis and renal branch patency by angiography, duplex scan, and morphological analysis.
All the renal arteries remained patent after re-evaluation in both groups. Aneurysmal sac thrombosis was absent in the control group, whereas in the stent group it was present in 66.7% of aneurysmal sacs (p=0.061).The mean final aneurysm sac diameter was significantly lower in the stent group (mean estimated reduction, 6.90 mm; p=0.021). The proximal neck diameter decreased significantly in the stent group (mean difference, 2.51 mm; p=0.022) and grew significantly in the control group (mean difference, 3.02 mm; p=0.007). The distal neck diameter increased significantly in the control group (mean difference, 3.24 mm; p=0.017). There were no significant findings regarding distal neck measurements in the stent group.
The MFMSs remained patent and did not obstruct the renal arteries within 4 weeks. In the stent group, the device was also associated with a significant decrease in aneurysmal sac diameter and a large proportion (albeit non-significant) of aneurysmal sac thrombosis.
我们旨在分析多层血流调节支架(MFMS)在胸腹主动脉瘤(TAAA)中的血流动力学效应。
我们在实验猪模型的胸腹主动脉瘤中分析了 MFMS 的血流动力学效应。我们将 18 头猪随机分为支架组和对照组,并进行了人工牛心包跨肾动脉瘤的制作。在支架组,立即植入 MFMS(Cardiatis,Isnes,比利时)。4 周后,我们通过血管造影、双功扫描和形态学分析评估动脉瘤囊血栓形成和肾分支通畅性。
两组肾动脉在重新评估时均保持通畅。对照组动脉瘤囊中未见血栓形成,而支架组中 66.7%的动脉瘤囊中存在血栓形成(p=0.061)。支架组的最终动脉瘤囊直径明显较小(平均估计减少 6.90 毫米;p=0.021)。支架组的近端颈部直径明显减小(平均差异 2.51 毫米;p=0.022),对照组的近端颈部直径明显增大(平均差异 3.02 毫米;p=0.007)。对照组的远端颈部直径明显增大(平均差异 3.24 毫米;p=0.017)。支架组远端颈部测量无明显变化。
在 4 周内,MFMS 保持通畅,未阻塞肾动脉。在支架组,该装置还与动脉瘤囊直径显著减小和动脉瘤囊血栓形成比例较高(尽管无统计学意义)相关。